Malic Acid

Malic Acid

SCHEMBL260836

C=CC(=O)OCCCO.O=C(O)CC(O)C(=O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDRD2HTR1BHTR1DHTR1F

The experimentally established mechanism targets of Malic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.50
ALDH1A1 P00352 4/20 0.50
CYP3A4 P08684 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 1/20 0.46
TP53 P04637 3/20 0.42
HIF1A Q16665 3/20 0.42
HSD17B10 Q99714 1/20 0.42
THRB P10828 2/20 0.36
MAPK1 P28482 1/20 0.35
TET2 Q6N021 3/20 0.34
TET3 O43151 1/20 0.34
TET1 Q8NFU7 1/20 0.34
OR51E2 Q9H255 1/20 0.31
HCAR2 Q8TDS4 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malic Acid SCHEMBL261227 0.90 TSHR (0.63) TSHRALDH1A1CYP3A4SMN1; SMN2HPGD
Aspartic Acid SCHEMBL28264636 0.83 TSHR (0.49) TSHRALDH1A1CYP3A4SMN1; SMN2HPGD
Hydrogen Peroxide SCHEMBL28304846 0.83 TSHR (0.71) TSHRALDH1A1CYP3A4SMN1; SMN2HPGD
Lactic Acid SCHEMBL27685519 0.82 TSHR (0.55) TSHRALDH1A1CYP3A4SMN1; SMN2HPGD
Bicarbonate SCHEMBL27397663 0.81 TSHR (0.68) TSHRALDH1A1CYP3A4SMN1; SMN2HPGD
SCHEMBL26117 0.81
SCHEMBL2851828 0.81 TSHR (0.74) TSHRALDH1A1CYP3A4SMN1; SMN2HPGD
SCHEMBL27858215 0.80 TSHR (0.57) TSHRALDH1A1CYP3A4SMN1; SMN2HPGD
Succinic Acid SCHEMBL27825760 0.80 TSHR (0.61) TSHRALDH1A1CYP3A4SMN1; SMN2HPGD
Acrylic Acid SCHEMBL2973647 0.79 TSHR (0.65) TSHRALDH1A1CYP3A4SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110007562-A Photopolymerizable unsaturated-resin and photosensitive resin composition containing the photopolymerizable unsaturated-resin 罗门哈斯电子材料韩国有限公司 2019-07-12 CN claimed
CN-103890659-A Photopolymerizable unsaturated resin, photosensitive resin composition containing the same, and light-shielding spacer and liquid crystal display device prepared therefrom ROHM & HAAS ELECT MAT 2014-06-25 CN claimed
CN-102681344-A Photosensitive resin composition, low dielectric constant light shielding layer and liquid crystal display apparatus using the same ROHM & HAAS ELECT MAT 2012-09-19 CN claimed
US-11667730-B2 Oxime ester compound and photopolymerization initiator containing the same ADEKA CORPORATION (JP) 2023-06-06 US disclosed
EP-3339331-B1 COMPOSITION ADEKA CORP (JP) 2022-02-16 EP disclosed
CN-106132929-B Oxime ester compound and photopolymerization initiator containing the same 株式会社艾迪科 2020-06-19 CN disclosed
EP-3176153-B1 NOVEL POLYMERIZATION INITIATOR AND RADICALLY POLYMERIZABLE COMPOSITION CONTAINING SAME ADEKA CORP (JP) 2020-04-08 EP disclosed
US-10189847-B2 Oxime ester compound and photopolymerization initiator containing said compound ADEKA CORPORATION (JP) 2019-01-29 US disclosed
CN-108699183-A Composition and new compound 株式会社艾迪科 2018-10-23 CN disclosed
CN-108473609-A Photosensitive composite and new compound 株式会社艾迪科 2018-08-31 CN disclosed
CN-108369831-A Conductive paste 株式会社艾迪科 2018-08-03 CN disclosed
EP-2145880-A1 NOVEL EPOXY COMPOUND, ALKALI-DEVELOPABLE RESIN COMPOSITION, AND ALKALI-DEVELOPABLE PHOTOSENSITIVE RESIN COMPOSITION Adeka Corporation (JP) 2010-01-20 EP disclosed
CN-100580555-C Alkaline developable resin composition ADEKA CORP 2010-01-13 CN disclosed
EP-2128132-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR COMPRISING THE COMPOUND Adeka Corporation (JP) 2009-12-02 EP disclosed
US-20090292039-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME ADEKA CORPORATION (JP) 2009-11-26 US disclosed
EP-2072500-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE COMPOUND Adeka Corporation (JP) 2009-06-24 EP disclosed
US-20070269720-A1 Alkali-Developable, Colored Photosensitive Resin Composition and Color Filter Using The Alkali-Developable, Colored Photosensitive Resin Composition TOPPAN PRINTING CO., LTD. (JP) 2007-11-22 US disclosed
CN-101023394-A Colored alkali developable photosensitive resin composition, and color filter using said colored alkali developable photosensitive resin compositoin TOPPAN PRINTING CO LTD (JP) 2007-08-22 CN disclosed
CN-1885162-A Alkali developing photosensitive resin composition ADEKA CORP (JP) 2006-12-27 CN disclosed
CN-1860415-A Alkali developable resin composition ASAHI DENKA CO LTD (JP) 2006-11-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667730-B2 Oxime ester compound and photopolymerization initiator containing the same OXER1, CYP4A11, CYP4F11 TSHR 344/4885ALDH1A1 2056/4885CYP3A4 27/4885
US-10189847-B2 Oxime ester compound and photopolymerization initiator containing said compound PPOX, CCNO, MRTO4 TSHR 2007/4885ALDH1A1 1193/4885CYP3A4 370/4885
US-20090292039-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME OXER1, CYP4A11, CYP4F11 TSHR 429/4885ALDH1A1 2106/4885CYP3A4 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.